�y��vlog

Rich in protein growth factors, they can stimulate the healing process.

Monoclonal antibodies -- lab-made proteins that mimic our natural antibodies and bind to specific proteins to treat diseases -- have emerged as a promising treatment for chronic pain by targeting nerve growth factor and sequestering it.

Instead of repressing tumor-suppressor genes, this form of EZH2 drives rapid protein production and activates growth factors like TGF-β, fostering an environment around the tumor that promotes cancer progression despite androgen receptor inhibition.

They achieved this with the targeted and controlled treatment of embryonic mouse stem cells with growth factors.

The paper explains the mechanism of "cross talk" between two cellular pathways, one initiated by proteins known as growth factors and by their cellular receptors.